Advertisement

Lung Cancer pp 118-141 | Cite as

Surgical Treatment of Locally Advanced Non-Small Cell Lung Cancer

  • Stephen G. Swisher
Part of the M.D. Anderson Cancer Care Series book series (MDCCS)

Keywords

Induction Chemotherapy Malignant Pleural Effusion Prophylactic Cranial Irradiation Lung Cancer Staging Chest Wall Resection 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings

  1. Anderson TM, Moy PM, Holmes EC. Factors affecting survival in superior sulcus tumors. J Clin Oncol 1986;4:1598–1603.PubMedGoogle Scholar
  2. Andre F, Grunenwald D, Pignon JP, et al. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000;18:2981–2989.PubMedGoogle Scholar
  3. Attar S, Krasna MJ, Sonett JR, et al. Superior sulcus (Pancoast) tumor: experience with 105 patients. Ann Thorac Surg 1998;66:193–198.CrossRefPubMedGoogle Scholar
  4. Bueno R, Richards WG, Swanson SJ, et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000;70:1826–1831.CrossRefPubMedGoogle Scholar
  5. Choy H, Akerley W, Safran H, et al. Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer. J Clin Oncol 1994;12:2682–2686.PubMedGoogle Scholar
  6. Dartevelle PG, Chapelier AR, Macchiarini P, et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993;105:1025–1034.PubMedGoogle Scholar
  7. Dillman RO, Herndon J, Seagren SL, et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of Cancer and Leukemia Group B (CALGB) 8433 trial. J Natl Cancer Inst 1996;88:1210–1215.PubMedGoogle Scholar
  8. Ferguson MK, Reeder LB, Mick M. Optimizing selection of patients for major lung resection. J Thorac Cardiovasc Surg 1995;109:275–281.CrossRefPubMedGoogle Scholar
  9. Gandhi S, Walsh GL, Komaki R, et al. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg 1999; 68:1778–1784.CrossRefPubMedGoogle Scholar
  10. Ginsberg RJ, Rubinstein LV, for the Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995;60:615–622.CrossRefPubMedGoogle Scholar
  11. Gressen EL, Curran WJ Jr. Effectiveness of radiation therapy on non-small-cell lung cancer. Clinical Lung Cancer 2001;2:182–194.PubMedCrossRefGoogle Scholar
  12. Kearney DJ, Lee TH, Reilly JJ, et al. Assessment of operative risk in patients undergoing lung resection. Importance of predicted pulmonary function. Chest 1994;105:753–759.PubMedGoogle Scholar
  13. Kubota K, Furuse K, Kawahara M, et al. Role of radiotherapy in combined modality treatment of locally advanced non-small-cell lung cancer. J Clin Oncol 1994;12:1547–1552.PubMedGoogle Scholar
  14. Luzzi L, Paladini P, Ghiribelli C, et al. Assessing the prognostic value of the extent of mediastinal lymph node infiltration in surgically-treated non-small cell lung cancer (NSCLC). Lung Cancer 2000;30:99–105.CrossRefPubMedGoogle Scholar
  15. Macchiarini P, Chapelier AR, Monnet I, et al. Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer. Ann Thorac Surg 1994;57:966–973.PubMedCrossRefGoogle Scholar
  16. Maurel J, Martinez-Trufero J, Artal A, et al. Prognostic impact of bulky mediastinal lymph nodes (N2>2.5 cm) in patients with locally advanced non-small-cell lung cancer (LA-NSCLC) treated with platinum-based induction chemotherapy. Lung Cancer 2000;30:107–116.CrossRefPubMedGoogle Scholar
  17. Mitchell JD, Mathisen DJ, Wright CD, et al. Clinical experience with carinal resection. J Thorac Cardiovasc Surg 1999;17:39–52.Google Scholar
  18. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710–1717.PubMedGoogle Scholar
  19. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. Chest 1997;111:1719–1723.Google Scholar
  20. Nesbitt JC, Putnam JB Jr, Walsh GL, et al. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg 1995;60:466–472.CrossRefPubMedGoogle Scholar
  21. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1997. CA Cancer J Clin 1997;47:5–27.PubMedGoogle Scholar
  22. Pisters KM, Ginsberg RJ, Giroux DJ, et al, for the Bimodality Lung Oncology Team. Induction chemotherapy before surgery for early-stage lung cancer: a novel approach. J Thorac Cardiovasc Surg 2000;119:429–439.CrossRefPubMedGoogle Scholar
  23. Rao V, Todd TR, Kuus A, et al. Exercise oximetry versus spirometry in the assessment of risk prior to lung resection. Ann Thorac Surg 1995;60:603–608.CrossRefPubMedGoogle Scholar
  24. Rendina EA, Venuta F, De Giacomo T, et al. Sleeve resection and prosthetic reconstruction of the pulmonary artery for lung cancer. Ann Thorac Surg 1999; 68:995–1001.CrossRefPubMedGoogle Scholar
  25. Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999;26:7–14.CrossRefPubMedGoogle Scholar
  26. Roth JA, Atkinson EN, Fossella F, et al. Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. Lung Cancer 1998;21:1–6.CrossRefPubMedGoogle Scholar
  27. Rusch VW, Giroux DJ, Kraut MJ, et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Thorac Cardiovasc Surg 2001;121:472–483.CrossRefPubMedGoogle Scholar
  28. Sause W, Kolesar P, Taylor S IV, et al. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. Chest 2000;117:358–364.CrossRefPubMedGoogle Scholar
  29. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer. N Engl J Med 1992;326:524–530.PubMedCrossRefGoogle Scholar
  30. Tsuchiya R, Asamura H, Kondo H, et al. Extended resection of the left atrium, great vessels, or both for lung cancer. Ann Thorac Surg 1994;57:960–965.PubMedCrossRefGoogle Scholar
  31. Walsh GL, Morice RC, Putnam JB Jr, et al. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption. Ann Thorac Surg 1994;58:704–710.PubMedCrossRefGoogle Scholar
  32. Walsh GL, O’Connor M, Willis KM, et al. Is follow-up of lung cancer patients after resection medically indicated and cost-effective? Ann Thorac Surg 1995; 60:1563–1570.CrossRefPubMedGoogle Scholar
  33. Weiner P, Man A, Weiner M, et al. The effect of incentive spirometry and inspiratory muscle training on pulmonary function after lung resection. J Thorac Cardiovasc Surg 1997;113:552–557.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 2003

Authors and Affiliations

  • Stephen G. Swisher

There are no affiliations available

Personalised recommendations